Non-Invasive Monitoring Systems, Inc. is primarily engaged in the business of research, development, manufacture and marketing of a line of motorized, non-invasive, whole body, periodic acceleration platforms, which are intended as aids to manage local circulation and temporary relief of minor aches and pains, produce local muscle relaxation and reduce morning stiffness. The Company's products include Whole Body Periodic Acceleration (WBPA) Therapeutic Devices and LifeShirt. It is primarily engaged in the business of the development of computer-assisted, non-invasive diagnostic monitoring devices and related software designed to detect abnormal respiratory, cardiac and other medical conditions from sensors placed externally on the body's surface. Its products are derivatives of its original acceleration platform, the AT-101, and are intended for use in homes, wellness and fitness centers, healthcare providers' offices and clinics, sports facilities and hospitals, among others.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCMKTS:NIMU
- CUSIP: N/A
- Web: www.nims-inc.com/
- Market Cap: $11.85 million
- Outstanding Shares: 79,007,000
- 52 Week Range: $0.07 - $0.20
Sales & Book Value:
- Trailing P/E Ratio:
- P/E Growth:
- Annual Revenue: $6,000.00
- Price / Sales: 1,975.18
- Book Value: ($0.04) per share
- Price / Book: -3.75
- EBIDTA: ($649,249.00)
- Return on Assets: -501.99%
- Current Ratio: 0.03%
- Quick Ratio: 0.03%
- Average Volume: 6,605 shs.
- Beta: 3.29
Frequently Asked Questions for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
What is Non-Invasive Monitoring Systems' stock symbol?
Non-Invasive Monitoring Systems trades on the OTCMKTS under the ticker symbol "NIMU."
Who are some of Non-Invasive Monitoring Systems' key competitors?
Some companies that are related to Non-Invasive Monitoring Systems include Pain Therapeutics (PTIE), ReWalk Robotics Ltd (RWLK), Eleven Biotherapeutics (EBIO), OncoSec Medical Incorporated (ONCS), HTG Molecular Diagnostics (HTGM), G1 THERAPEUTICS (GTHX), Aviragen Therapeutics (AVIR), Galena Biopharma (GALE), Streamline Health Solutions (STRM), Aradigm Corporation (ARDM), Kitov Pharmaceuticals Holdings (KTOV), Onconova Therapeutics (ONTX), Trimel Pharmaceuticals Corp. (TRLPF), TearLab Corporation (TEAR), Heat Biologics (HTBX), Catalyst Biosciences (CBIO), Alliqua BioMedical (ALQA) and Delcath Systems (DCTH).
Who are Non-Invasive Monitoring Systems' key executives?
Non-Invasive Monitoring Systems' management team includes the folowing people:
- Jane H. Hsiao Ph.D., Chairman of the Board, Interim Chief Executive Officer
- Joseph J. Martin CPA, Chief Financial Officer, Treasurer
- Marvin A. Sackner M.D., Director
- Taffy Gould, Independent Director
- Morton J. Robinson M.D., Independent Director
- Steven D. Rubin Esq. J.D., Independent Director
- Subbarao V. Uppaluri Ph.D., Independent Director
How do I buy Non-Invasive Monitoring Systems stock?
Shares of Non-Invasive Monitoring Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Non-Invasive Monitoring Systems' stock price today?
MarketBeat Community Rating for Non-Invasive Monitoring Systems (OTCMKTS NIMU)MarketBeat's community ratings are surveys of what our community members think about Non-Invasive Monitoring Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Non-Invasive Monitoring Systems stock can currently be purchased for approximately $0.15.
Consensus Ratings for Non-Invasive Monitoring Systems (OTCMKTS:NIMU) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
Insider Ownership Percentage: 26.90%Insider Trades by Quarter for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/15/2014||James Joseph Martin||CFO||Buy||25,000||$0.11||$2,750.00|| |
|8/15/2014||Marvin Arthur Sackner||Director||Sell||1,733,250||$0.11||$190,657.50|| |
|11/7/2013||Marvin Arthur Sackner||Director||Sell||24,308||$0.36||$8,750.88|| |
|10/10/2013||Marvin Arthur Sackner||Director||Sell||6,032||$0.30||$1,809.60|| |
|10/7/2013||Marvin Arthur Sackner||Director||Sell||10,000||$0.30||$3,000.00|| |
|10/4/2013||Marvin Arthur Sackner||Director||Sell||20,000||$0.29||$5,800.00|| |
|9/6/2013||Marvin Arthur Sackner||Director||Sell||15,000||$0.33||$4,950.00|| |
|9/4/2013||Marvin Arthur Sackner||Director||Sell||40,000||$0.36||$14,400.00|| |
|8/27/2013||Marvin Arthur Sackner||Director||Sell||38,245||$0.38||$14,533.10|| |
|8/22/2013||Marvin Arthur Sackner||Director||Sell||91,448||$0.31||$28,348.88|| |
|8/9/2013||Marvin Arthur Sackner||Director||Sell||50,000||$0.22||$11,000.00|| |
|4/8/2013||Jane Ph D Hsiao||Chairman||Buy||20,000,000||$0.05||$1,000,000.00|| |
|4/8/2013||Phillip Md Et Al Frost||Major Shareholder||Buy||2,000,000||$0.05||$100,000.00|| |
Headline Trends for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
Latest Headlines for Non-Invasive Monitoring Systems (OTCMKTS:NIMU)
|MindChild Medical, Inc. Announces Clearance of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration (FDA) for the MERIDIAN™ M110 Fetal Monitoring System|
www.businesswire.com - January 17 at 7:12 PM
|CASMED Reports Preliminary Net Sales for the 2016 Fourth Quarter and Full Year|
globenewswire.com - January 10 at 8:57 AM
|NON INVASIVE MONITORING SYSTEMS INC /FL/ Files SEC form 10-Q, Quarterly Report|
biz.yahoo.com - December 15 at 7:46 PM
|NON INVASIVE MONITORING SYSTEMS INC /FL/ Financials|
finance.yahoo.com - October 8 at 10:51 AM
|Non-invasive Brain Trauma Monitoring Devices Market Analysis By Product, By End-use, And Segment Forecasts To 2024|
finance.yahoo.com - October 4 at 11:08 AM
|Dexcom Breaks Into the Scene With its Novel Continuous Glucose Monitoring Systems Challenging the Bigwigs …|
finance.yahoo.com - September 27 at 10:58 AM
|Global Hemoglobin A1c Monitoring Industry|
finance.yahoo.com - September 22 at 6:05 PM
|Eccrine Systems is Awarded $3.96M US Air Force Contract|
finance.yahoo.com - August 25 at 11:33 AM
|Non-invasive Brain Trauma Monitoring Devices Market Worth $15.1 Billion By 2024: Grand View Research, Inc.|
www.marketwatch.com - August 16 at 9:46 AM
|Hemodynamic Monitoring Systems Market Worth 1,143.7 Million USD by 2021|
finance.yahoo.com - August 15 at 8:40 AM
|Form 10-Q CAS MEDICAL SYSTEMS INC For: Jun 30|
www.streetinsider.com - August 5 at 6:40 PM
|CASMED to Report Second Quarter 2016 Financial Results and Hold Conference Call on August 4|
globenewswire.com - July 28 at 9:41 AM
|Glucose Biosensor Market Size & Forecast By End-use , By Region And Trend Analysis From 2015 To 2022|
finance.yahoo.com - July 27 at 9:27 AM
|PetPace, Ecopet Announce Distribution Agreement in Spain|
www.msn.com - June 30 at 8:57 PM
|MediBeacon™ Inc. Acquires Mannheim Pharma & Diagnostics|
www.bizjournals.com - June 10 at 9:23 AM
|Echo Therapeutics, Inc. Announces First Quarter 2016 Financial Results|
www.prnewswire.com - May 20 at 11:56 AM
|Hemodynamic Monitoring Devices Market Worth $1.4 Billion by 2024: Grand View Research, Inc.|
finance.yahoo.com - May 18 at 11:41 AM
Non-Invasive Monitoring Systems (NIMU) Chart for Sunday, July, 23, 2017